LIFT-AD trial did not meet primary endpoint of GST and key secondary endpoints of cognition (ADAS-Cog11) and function ...

Researchers at the Medical College of Georgia at Augusta University are searching for a better way to understand why many men ...

Athira Pharma said on Tuesday its investigative drug failed to meet the main goal in a mid-to-late stage trial in patients ...

Aging is a complex biological process that also takes place in the brain. Researchers have discovered that the gene activity ...

The Alzheimer’s Association is inviting Niagara County residents to join the fight to end Alzheimer’s disease by ...

Athira Pharma's trial of fosgonimeton for Alzheimer's disease patients failed to meet its primary endpoint. Bothell, Wash., biopharmaceutical company said Tuesday that neither the trial's primary ...

My experience has shown me how crucial it is to have strong public health infrastructure in place to support those affected ...

Learn how to distinguish between normal ageing and Alzheimers disease Understand common memory lapses cognitive changes and ...

Sept. 21. Dealing with Alzheimer’s disease goes beyond a diagnosis; it’s a journey that profoundly affects not only those directly impacted but also their loved ones who support them along the way.

All kinds of foods have been linked with fuelling better brain health. Professor June Andrews, a specialist dementia nurse ...

Athira Pharma (ATHA) stock cratered post-market after the company said a Phase 2/3 study of its drug Alzheimer’s drug candidate fosgonimeton failed to meet its primary endpoint.